HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 109-120 of 1,979
Drug study icon
CompletedACTRN12622000669796

Intranasal insulin for neurocognition in Bipolarity

Official study title

The efficacy of adjunctive intranasal insulin for the treatment of neurocognitive dysfunction in bipolar disorder: A 12-week double blind randomised placebo controlled clinical trial.

This study has finished and is no longer accepting participants.

In Hawthorn
BipolarityInterventional studyAges 18–55
Countries
Australia
Sponsor
Swinburne University of Technology
Behavioral study icon
CompletedACTRN12618001193268

REsearch into COgnitive and behavioural VERsatility (RECOVER) tailored psychological intervention for early stage Bipolarity.

Official study title

A randomised, controlled trial of the RECOVER tailored psychological intervention for improving global functioning in early stage bipolar disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Parkville
BipolarityInterventional studyAges 15–25
Countries
Australia
Sponsor
Orygen
Other study type icon
Active Not RecruitingACTRN12610001002077

Wellbeing Group Program for Adults Recently Diagnosed with Bipolarity type II

Official study title

A Randomised Controlled Trial of a Wellbeing Group Program Versus Treatment as Usual for Adults Recently Diagnosed with Bipolar II Disorder

This study is no longer accepting new participants.

Location not clearly listed
BipolarityInterventional studyAges 20–70
Countries
Sponsor
University of New South Wales
Other study type icon
RecruitingNCT06779578

Bipolar or monopolar pulsed radiofrequency for trigeminal neuralgia

About this title

Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia

Read the official source — NCT06779578
Official study title

The Efficacy and Safety of Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia: An Exploratory Study

Multiple locations, including Alexandria
BipolarityPlacebo comparison
Countries
Egypt
Sponsor
Alexandria University
Drug study icon
CompletedEUCTR 2015-000323-86

A randomised, parallel group, double blind, placebo controlled, add on clinical trial to investigate whether the lithium mimetic, ebselen, can reduce symptoms of hypomania and mania in bipolar pati...

This study has finished and is no longer accepting participants.

Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.

In Oxford
BipolarityHistorical research recordAges 18–70
Countries
United Kingdom
Sponsor
University of Oxford (University)
Drug study icon
Not recruitingEUCTR 2019-002778-30

Memantine versus placebo for manic symptoms in adolescents with bipolarity

About this title

Double-blind, randomized, monocentric study to evaluate the efficacy and safety of memantine in adolescents with Bipolar Disorder

Read the official source — 2024-516713-21-00
Official study title

Efficacy and safety of memantine as antimanic and mood-stabilizing medication for adolescents with Bipolar Disorder: a multi-center, randomized, double-blind, placebo-controlled clinical trial

Original registry wording; source language not specified.

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

In Rome
BipolarityHistorical research record
Countries
Italy
Sponsor
IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.